# VAsopressin and STeroids in Addition to Adrenaline in Cardiac Arrest - a Randomized Clinical Trial

> **NCT05139849** · PHASE3 · RECRUITING · sponsor: **Tiohundra AB** · enrollment: 1276 (estimated)

## Conditions studied

- Cardiac Arrest;In-hospital Cardiac Arrest; Methylprednisolone; Vasopressin; Adrenaline; Randomized Clinical Trial

## Interventions

- **DRUG:** Vasopressin; Methylprednisolone; Hydrocortisone
- **DRUG:** Sodium chloride

## Key facts

- **NCT ID:** NCT05139849
- **Lead sponsor:** Tiohundra AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-17
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-04-30
- **Target enrollment:** 1276 (ESTIMATED)
- **Last updated:** 2022-01-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05139849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05139849, "VAsopressin and STeroids in Addition to Adrenaline in Cardiac Arrest - a Randomized Clinical Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05139849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*